Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Accessory breast tissue

Essential points for quick revision.

Saved on this device

Synopsis

Recognise accessory breast and nipple tissue along the embryological milk line, distinguish it from nodal and skin masses, and investigate new focal change using the same diagnostic standards as pectoral breast tissue.

  • Accessory breast tissue results from incomplete regression of the embryological mammary ridge and occurs most often in the axilla, with or without an accessory nipple.
  • Hormonal responsiveness can cause cyclical tenderness, pregnancy-related enlargement or milk secretion, which often makes previously unnoticed tissue symptomatic.
  • Examination should decide whether an axillary fullness is glandular tissue, a lymph node, lipoma, epidermal cyst, hidradenitis or another soft-tissue mass.

Investigation priorities

01
Targeted axillary ultrasoundFirst step

Localise the structure and distinguish glandular tissue from node, cyst, lipoma or abscess.

Management branches

Pregnancy-change pathwayIdentify functional tissue without missing a lesion

During late pregnancy, a patient develops bilateral soft axillary fullness that is tender and enlarges with breast engorgement.

  1. Examine both axillae and breasts, documenting whether tissue is diffuse and symmetrical and checking for a dominant mass, infection, skin lesion or abnormal node.
  2. Use ultrasound if anatomy is uncertain or any focal feature exists; avoid assuming every pregnancy-related axillary swelling is a node or abscess.
Elective-excision pathwayAddress persistent functional burden

Stable benign accessory tissue repeatedly chafes, restricts arm movement and causes substantial distress despite conservative measures.

Open full textbook Answer 2 questions
Sources and review status5 sources · checked 8 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 8 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom